Embolization Agents Market Trends & Developments 2034
Coverage: Embolization Agents Market covers analysis By Product (Coils, Plugs, Beads/Particles, Detachable Balloons, Glue, Sponge/Gelatin, Liquid Embolics, Sclerosants & Precipitating Agents); Application (Oncology, Neurology, Urology (PAE), Cardiology, Peripheral vascular diseases ); End User (Hospitals, Cardiac centers, Ambulatory surgical centers); and Geography
- Report Date : Mar 2026
- Report Code : TIPRE00025058
- Category : Life Sciences
- Status : Upcoming
- Available Report Formats :
- No. of Pages : 150
The Embolization Agents Market size is expected to reach US$ 7.10 Billion by 2034 from US$ 3.64 Billion in 2025. The market is anticipated to register a CAGR of 7.69% during 2026–2034.
Embolization Agents Market AnalysisThe global embolization agents market is witnessing robust adoption across interventional oncology, peripheral vascular disease, and neurovascular care. Procedure volumes continue to shift toward minimally invasive embolotherapy as hospitals expand interventional radiology suites and as evidence accumulates for durable occlusion using mechanical coils, vascular plugs, calibrated microspheres, and liquid embolics. Market growth is driven by multipurpose platforms (coils and plugs for rapid mechanical occlusion; PEG, trisacryl–gelatin, and other calibrated microspheres for targeted arterial blockade; and EVOH-based liquid embolics for complex lesions), broader indications (tumor devascularization, hemorrhage control, AVMs/AVFs), and ongoing portfolio upgrades (radiopaque beads, hydrogel expansion coils, large-volume detachable coils).
Embolization Agents Market OverviewEmbolization agents are materials designed to occlude blood vessels selectively and durably. Core categories include coils (detachable and pushable), plugs, beads/particles (calibrated microspheres and PVA), detachable balloons, glues, sponges/gelatin, liquid embolics (e.g., EVOH/DMSO), sclerosants, and precipitating agents. These agents are delivered via catheters under fluoroscopic guidance to achieve mechanical or thrombogenic occlusion, with use spanning oncology (e.g., uterine fibroids, HCC metastases), neurology (AVMs/aneurysms), urology (PAE), cardiology (aneurysm/hemorrhage management), and peripheral vascular diseases. Recent advances emphasize visibility, packing density, controllability, and compatibility with microcatheters and diagnostic catheters to minimize non-target embolization and procedural time.
Strategic InsightsEmbolization Agents Market Drivers and OpportunitiesMarket Drivers:
- Rising Cancer and Cardiovascular Burden: The global increase in chronic diseases, particularly cancer and cardiovascular conditions, is driving the demand for surgery-sparing, catheter-based embolization as a preferred treatment modality.
- Technology Enhancements Across Agents: Continuous innovation is yielding superior devices, such as hydrogel-expanding coils for higher packing density, radiopaque/color-enhanced beads for improved visualization, and non-adhesive liquid embolics with highly controlled deposition kinetics.
- Workflow Gains from High-Volume Coils: New device designs, like large-volume coils and quick-deployment vascular plugs, reduce the number of devices needed, thereby decreasing procedure times, reducing radiation exposure, and improving overall workflow efficiency in the Cath Lab.
Market Opportunities:
- Drug-Device Combinations, Radioembolization: The integration of embolics with therapeutic agents (e.g., drug-eluting beads) and advancements in radioembolization techniques allow for improved local tumor control and more precise, personalized therapy delivery.
- Portfolio Integration with Advanced Microcatheters: Opportunities exist for vendors to seamlessly integrate their embolization agents with specialized, flexible microcatheters and sophisticated navigation systems to safely reach increasingly tortuous and distal anatomies in the neurovascular space.
- Clinical Evidence for Benign Prostatic Hyperplasia (PAE): Expanding clinical evidence in non-oncology applications, such as trauma control, gastrointestinal hemorrhage management, and especially the rapidly growing Prostatic Artery Embolization (PAE) procedure, broadens the market footprint.
The embolization agents market share is analyzed across various segments to provide a clearer understanding of its structure, growth potential, and emerging trends. Below is the standard segmentation approach used in most industry reports:
By Product:
- Coils: Detachable and pushable metallic coils for mechanical occlusion and thrombogenesis
- Plugs: Single-device occluders for rapid closure in high-flow vessels
- Beads/Particles: Calibrated microspheres (PVA, trisacryl–gelatin, hydrogel)
- Detachable Balloons: Temporary or permanent occlusion devices, mostly neurovascular
- Glue: Rapid-setting liquid embolics (e.g., NBCA)
- Sponge/Gelatin: Temporary agents for hemorrhage control
- Liquid Embolics: Non-adhesive, precipitating agents like EVOH/DMSO
- Sclerosants & Precipitating Agents: Ethanol or chemicals for permanent vessel closure
By Application:
- Oncology
- Neurology
- Urology (PAE)
- Cardiology
- Peripheral vascular diseases
By End User:
- Hospitals
- Cardiac centers
- Ambulatory surgical centers
By Geography:
- North America
- Europe
- Asia Pacific
- South & Central America
- Middle East & Africa
North America is expected to remain the dominant market, while Asia Pacific is anticipated to witness the fastest growth during the forecast period, driven by the scaling of interventional oncology services. The embolization agents market shows a different growth trajectory in each region due to factors such as interventional capacity, clinical adoption, and healthcare funding. Below is a summary of market share and trends by region:
North America
- Market Share: Leads globally due to advanced interventional capacity and high adoption rates.
- Key Drivers: Widespread integration of dedicated interventional radiology suites.
- Trends: Focus on innovation, particularly hydrogel-expanding coils and advanced liquid embolics for complex neurovascular cases.
Europe
- Market Share: Significant share, supported by established oncologic embolization programs.
- Key Drivers: Established use of calibrated microspheres for chemoembolization.
- Trends: Increasing integration of advanced imaging (fusion imaging) with embolization procedures.
Asia-Pacific
- Market Share: Fastest-growing region due to rapid healthcare modernization.
- Key Drivers: Hospital network expansion and investment in state-of-the-art angiography systems.
- Trends: Rapid adoption of standard coils and PVA particles, with a move toward drug-eluting beads (DEB) in key centers.
South and Central America
- Market Share: Emerging market with growth potential driven by public-private investments.
- Key Drivers: Trauma care upgrades driving demand for rapid hemorrhage control agents.
- Trends: Cloud-based, cost-effective embolization solutions are gaining traction, especially in trauma settings.
Middle East and Africa
- Market Share: Developing market with strong growth potential due to rising healthcare investments.
- Key Drivers: National e-health strategies and hospital modernization initiatives.
- Trends: Implementation of embolization in integrated care models for vascular and oncologic services.
Competitive Landscape and Strategic Moves
Competition is robust, characterized by major, diversified med-tech conglomerates such as Medtronic, Terumo Corporation, and Boston Scientific Corporation, competing fiercely with specialized players like Penumbra, Inc. and Merit Medical Systems Inc.
This competitive environment pushes vendors to differentiate through:
- Innovation in Material Science: Developing radiopaque beads and hydrogel-expanding materials to improve visibility and packing density.
- Portfolio Completeness: Offering a full range of products, from coils and plugs to liquid embolics and specialized microcatheters.
- Clinical Evidence Generation: Funding trials (like Medtronic’s PELE IDE study) to expand indications and solidify procedural adoption.
- Medtronic
- Terumo Corporation
- Cook Medical LLC
- Boston Scientific Corporation
- Abbott
- Stryker Corporation
- Penumbra, Inc.
- Merit Medical Systems Inc.
- DePuy Synthes
Disclaimer: The companies listed above are not ranked in any particular order.
Embolization Agents Market News and Recent Developments- Medtronic enrolled the first patient in the PELE IDE clinical trial for the Onyx™ Liquid Embolic System, evaluating its safety and effectiveness in U.S. patients with peripheral arterial hemorrhage. The EMBOLISE trial, published in The New England Journal of Medicine (Nov 2024), demonstrated that adjunctive middle meningeal artery embolization with Onyx™ significantly reduces recurrence risk in chronic subdural hematoma compared to surgery alone. The Onyx™ system remains a core neurovascular product, developed over 20 years for AVMs and neurovascular embolization.
- Terumo Corporation’s MicroVention subsidiary published one-year results from the CLEVER study on the WEB™ 17 intrasaccular aneurysm embolization system, showing high occlusion rates (~86.5% for ruptured and ~82.4% for unruptured aneurysms) with low complication rates. Terumo has also expanded its embolization portfolio to include LifePearl™ drug-eluting microspheres, AZUR™ hydrogel-coated coils and plugs, and new systems such as OPUSWAVE® and DualView®, supporting comprehensive neurovascular care.
The "Embolization Agents Market Size and Forecast (2021–2034)" report provides a detailed analysis of the market covering below areas:
- Embolization Agents Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Embolization Agents Market trends, as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- Embolization Agents Market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments in the Embolization Agents Market
- Detailed company profiles
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Application and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Opportunities in the Embolization Agents Market include drug-eluting beads, radioembolization, image-guided dosimetry, and integration with advanced microcatheters and navigation systems.
North America leads the Embolization Agents Market due to advanced interventional radiology capacity, high adoption rates, and integration of specialized embolization suites.
Coils, plugs, calibrated microspheres, liquid embolics, and advanced detachable balloons are key products driving the Embolization Agents Market.
Growth in the Embolization Agents Market is fueled by increasing cancer and cardiovascular disease burden, technological enhancements in coils, plugs, and liquid embolics, and improved workflow efficiency in interventional radiology.
The Embolization Agents Market is expected to reach US$ 7.10 billion by 2034, driven by rising adoption of minimally invasive embolotherapy across oncology, neurovascular, and cardiovascular procedures.
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For